These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 33761638

  • 21. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
    Zhou G, Lu M, Chen J, Li C, Zhang J, Chen J, Shi X, Wu S.
    Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
    [Abstract] [Full Text] [Related]

  • 22. Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment.
    Cho HJ, Kim SS, Nam JS, Kim JK, Lee JH, Kim B, Wang HJ, Kim BW, Lee JD, Kang DY, Kim JH, Jae YM, Hwang JC, Shin SJ, Lee KM, Cho SW, Cheong JY.
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):181-189. PubMed ID: 27839726
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
    Lian D, Wang ZZ, Liu NS.
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN, Ge DW, Tang J, Yang J, Yan JW, Qiu JJ, Yin ZW, Ni Y, Zhao L, Chen X, Yang L.
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
    Hong Q, Fang J, Pang Y, Zheng J.
    Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
    [Abstract] [Full Text] [Related]

  • 29. Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.
    Cai H, Lin L, Cai H, Tang M, Wang Z.
    Int J Mol Sci; 2014 Jan 06; 15(1):560-73. PubMed ID: 24398981
    [Abstract] [Full Text] [Related]

  • 30. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W, Zhao ZY, Shi L, Yuan WD.
    Diagn Pathol; 2015 Jul 21; 10():116. PubMed ID: 26194657
    [Abstract] [Full Text] [Related]

  • 31. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P, Ding J, Fu S.
    Pathol Res Pract; 2017 Mar 21; 213(3):194-198. PubMed ID: 28214202
    [Abstract] [Full Text] [Related]

  • 32. MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.
    Cheng DD, Yu T, Hu T, Yao M, Fan CY, Yang QC.
    Oncotarget; 2015 Dec 15; 6(40):42761-72. PubMed ID: 26498360
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B, Zhou N, Hu T, Zhao W, Wu D, Wang S.
    J Cell Physiol; 2019 Aug 15; 234(8):13464-13480. PubMed ID: 30624782
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.
    Allen-Rhoades W, Kurenbekova L, Satterfield L, Parikh N, Fuja D, Shuck RL, Rainusso N, Trucco M, Barkauskas DA, Jo E, Ahern C, Hilsenbeck S, Donehower LA, Yustein JT.
    Cancer Med; 2015 Jul 15; 4(7):977-88. PubMed ID: 25784290
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.